NCT05737901 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Cook DJ, Moradkhani A, Douglas KS, Prinsen SK, Fischer EN, Schroeder DR
Patient education self-management during surgical recovery: combining mobile (iPad) and a content management system. Telemed J E Health. 2014 Apr;20(4):312-7. doi: 10.1089/tmj.2013.0
Greysen SR, Khanna RR, Jacolbia R, Lee HM, Auerbach AD
Tablet computers for hospitalized patients: a pilot study to improve inpatient engagement. J Hosp Med. 2014 Jun;9(6):396-9. doi: 10.1002/jhm.2169. Epub 2014 Feb 13.
Noor Hanita Z, Khatijah LA, Kamaruzzaman S, Karuthan C, Raja Mokhtar RA
A pilot study on development and feasibility of the 'MyEducation: CABG application' for patients undergoing coronary artery bypass graft (CABG) surgery. BMC Nurs. 2022 Feb 4;21(1):40
van Steenbergen GJ, van Veghel D, Ter Woorst J, van Lieshout D, Dekker L
IMPROV-ED trial: eHealth programme for faster recovery and reduced healthcare utilisation after CABG. Neth Heart J. 2021 Feb;29(2):80-87. doi: 10.1007/s12471-020-01508-9. Epub 2020

Effect of Different Discharge Training Methods On Readiness and Self-Efficacy for Discharge After Coronary Artery Bypass Surgery: A Randomized Uncontrolled Clinical Study

Details for clinical trial NCT05737901

Clinical trial NCT05737901 - References